Upgrade to SI Premium - Free Trial

Globus Medical (GMED) PT Raised to $85 at BTIG

August 5, 2021 5:51 AM
BTIG analyst Ryan Zimmerman raised the price target on Globus Medical (NYSE: GMED) to $85.00 (from $83.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles